%0 Journal Article
%T Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg£¿, a pegfilgrastim biosimilar in healthy subjects
%A Barbara Gastl
%A Dirk Lehnick
%A Hendrik Wessels
%A Josef H£¿fler
%A Karsten Roth
%A Ruediger Jankowsky
%J Archive of "Pharmacology Research & Perspectives".
%D 2019
%R 10.1002/prp2.503
%K biosimilar
%K filgrastim
%K myelosuppressive chemotherapy
%K Neulasta
%K neutropenia
%K oncology
%K pegfilgrastim
%K Pelmeg
%K supportive care
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691757/